Compatibility «Xefocam» and «Telmista»
Between «Xefocam» and «Telmista» found 2 dangerous and 6 negative interactions, joint admission is not recommended without consulting a doctor.
Interaction tableCompare |
Telmista |
✘Xefocam [Lornoxicam] Analogs | |
✘Telmista [Telmisartan] Analogs |
-
Interactions Xefocam with Telmista
-
Dangerous interactions
It weakens the diuretic effect and increases the nephrotoxicity of diuretics, reduces the antihypertensive drugs. In elderly people with reduced BCC (including those receiving diuretic therapy) or with impaired renal function, the combined use of NSAIDs, in pm, selective COX-2 inhibitors with ARA II, including telmisartan, may lead to deterioration of renal function, including possible acute renal failure. -
Negative interactions
- Beta‑blockers - reduces the hypotensive effectiveness of angiotensin II receptor blockers;. Kidney function should be monitored periodically in patients receiving telmisartan and NSAIDs. The antihypertensive effect of ARA II, including telmisartan, can be weakened by NSAIDs, including selective COX-2 inhibitors. The risk may increase when combined with other medications that can also provoke hyperkalemia (salt substitutes containing potassium, potassium‑sparing diuretics, ACE inhibitors, angiotensin II receptor antagonists, nonsteroidal anti‑inflammatory drugs (NSAIDs, including selective COX-2 inhibitors), heparin, immunosuppressants (cyclosporine or tacrolimus) and co-trimoxazole (trimethoprim + sulfamethoxazole). Concomitant use with ACE inhibitors or NSAIDs, including selective COX‑2 inhibitors, is accompanied by a lower risk of hyperkalemia, provided careful observance of precautions. Nonsteroidal anti‑inflammatory drugs NSAIDs (for example, acetylsalicylic acid in anti-inflammatory dosage regimens, COX-2 inhibitors and non-selective NSAIDs) can reduce the antihypertensive effect of angiotensin II receptor antagonists. -
Unclear interactions
NSAIDs, including selective COX-2 inhibitors. Nonsteroidal anti-inflammatory drugs (NSAIDs).
-
Dangerous interactions
Decoding the colors of interactions and contraindications
Dangerous | — | a pronounced negative interaction or contraindication. |
Negative | — | negative interaction or side effect that may reduce effectiveness. |
Positive | — | the interaction can SOMETIMES be used as a positive (often a dose adjustment is needed), or it is an indication of the drug. |
No | — | the drugs do NOT interact, which is separately indicated in the instructions. |
Unclear | — | the system failed to pre-assess the danger. |
Video instruction
Additional information
- Kiberis checks interactions and evaluates drug compatibility online right in the instructions thanks to the latest artificial intelligence technologies. The accuracy of finding is more than 95%, the accuracy of the hazard assessment is more than 80%. The online medical service takes into account all the drug groups of the selected drugs and all their components. And since the database contains 25,000 drugs with detailed instructions, not every pharmacologist can compete with our artificial intelligence. List of popular interactions.
- Why do I need to
- Avoid dangerous prescriptions for your patients.
- Check the contraindications.
- Evaluate the safety of therapy in the treatment of children.
- See the compatibility of drugs with alcohol (enter it as a drug).
- Point the doctor to the found interaction - you may need to adjust the therapy.
- The use of information about interactions is only possible as an introduction. This information should not be used to adjust therapy without consulting a specialist.
- The article is written: artificial intelligence Kiberis
- Sources: official instructions for medicines and their active substances, as well as inter-group interactions described in medical studies and textbooks.
- Total analyzed: 169,974,420 possible combinations of drugs and their components were found 412,510 interacting combinations.
- Medicine section: Standard evidence-based medicine
- The date of the last update of the interaction database: 2024-05-02
Category - medicine